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Abstract.  Two genetically distinct classes of low den- 
sity lipoprotein (LDL) receptor-deficient Chinese ham- 
ster ovary cell mutants, ldlB and ldlC, exhibit nearly 
identical pleiotropic defects in multiple medial and 
trans  Golgi-associated processes (Kingsley,  D., K.  F. 
Kozarsky,  M.  Segal, and M. Krieger.  1986. J.  Cell 
Biol.  102:1576-1585.).  In these mutants, the synthesis 
of virtually all N- and O-linked glycoproteins and of 
the major lipid-linked oligosaccharides is abnormal. 
The abnormal glycosylation of LDL receptors in ldlB 
and ldlC cells results in their dramatically reduced 
stability and thus very low LDL receptor activity. We 
have cloned and sequenced a human cDNA (LDLC) 
which corrects the mutant phenotypes of ldlC, but not 
ldlB,  cells. Unlike wild-type CHO or ldlB cells, ldlC 
cells had virtually no detectable endogenous LDLC 
mRNA, indicating that LDLC is likely to be the 
normal human homologue of the defective gene in 
ldlC cells. The predicted sequence of the human 
LDLC protein (ldlCp,  m83 kD) is not similar to that 
of any known proteins, and contains no major com- 
mon structural motifs such as transmembrane domains 
or an ER translocation signal sequence. We have also 
determined the sequence of the Caenorhabditis ele- 
gans ldlCp by eDNA cloning and sequencing. Its 
similarity to that of human ldlCp suggests  that ldlCp 
mediates a well-conserved cellular function. Im- 
munofluorescence studies with anti-ldlCp antibodies in 
mammalian cells established that ldlCp is a peripheral 
Golgi protein whose association with the Golgi is 
brefeldin A  sensitive. In ldlB cells, ldlCp was ex- 
pressed at normal levels; however, it was not as- 
sociated with the Golgi. Thus, a combination of so- 
matic cell and molecular genetics has identified a 
previously unrecognized protein, ldlCp, which is re- 
quired for multiple Golgi functions and whose periph- 
eral association with the Golgi is both LDLB depen- 
dent and brefeldin A  sensitive. 
I 
N euk~aryotes,  nascent secretory and integral membrane 
proteins, glycosaminoglycans, and glycolipids typically 
traverse the Golgi en route to their final destinations. 
Often, chemical modification of these molecules within the 
Golgi is essential for their stability or function. For example, 
mucin-type serine/threonine-linked  (O-linked) oligosaccha- 
rides are known to protect from rapid proteolysis  several 
cell surface proteins,  including the low density lipoprotein 
(LDL) t receptor (Krieger et al.,  1985), decay-accelerating 
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A;  EST, expressed  sequence  tag;  FGAM,  fluorescein-conjugated  goat 
anti-mouse IgGs;  FGAR,  fluorescein-conjugated  goat anti-rabbit IgGs; 
LDL,  low density lipoprotein;  LETC,  LDL endocytosis transfectants of 
ldlC  cells;  PHA,  phytohemagglutinin; TRHAM,  Texas red-conjugated 
horse anti-mouse IgG; WGA, wheat germ agglutinin;  WT,  wild-type. 
factor (Reddy et al., 1989), the Epstein-Barr virus envelope 
protein (Krieger et al., 1989), and glycophorin (Remaley et 
al., 1991). Also, asparagine-linked (N-linked) glycosylation 
is required for normal folding, assembly, and intracellular 
transport of proteins such as the vesicular stomatitis virus G 
protein and the influenza virus hemagglutinin protein (Rose 
and Doms,  1988; Doms et al.,  1993). Although previous 
biochemical and genetic analyses have uncovered a wealth of 
information about the molecular mechanisms underlying in- 
tracellular protein transport and processing  in the Golgi 
(Kornfeld and Kornfeld, 1985; Hirschberg and Snider, 1987; 
Rothman and Orci, 1992), much remains to be learned about 
the structure and function of the Golgi. 
To help define and analyze the gene products and functions 
required for normal Golgi activity, we have analyzed mutant 
CHO cells with defects in LDL receptor activity (Krieger et 
al., 1981, 1983, 1985; Krieger, 1983; Malmstrom and Krie- 
ger, 1991; Hobbie et al.,  1994). These mutants define nine 
complementation  groups,  designated  ldlA  through  ldlI 
(Kingsley and Krieger, 1984; Malmstrom and Krieger, 1991; 
Hobbie et al.,  1994). The LDL receptor deficiency of mu- 
tants in two of these groups, ldlB and ldlC, is a consequence 
of dramatically decreased LDL receptor stability due to ab- 
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Golgi (Kingsley et al.,  1986a).  At least in the case of ldlC 
cells, this aberrant processing and the resulting instability do 
not prevent the initial appearance of the abnormal receptors 
on the cell surface and do not alter the receptors' ligand- 
binding and endocytic properties (Kingsley et al.,  1986a; 
Reddy and Krieger,  1989). 
ldlB and ldlC exhibit nearly identical pleiotropic defects 
in medial and trans Golgi-associated processes, which result 
in the abnormal synthesis of virtually all N-linked, O-linked 
and lipid-linked glycoconjugates (Kingsley et al.,  1986a). 
The global nature of the glycosylation defects in these mu- 
tants was demonstrated both by examining the synthesis of 
several distinct molecules (LDL receptor, vesicular stomati- 
tis virus G protein, the major surface glycolipid GM3), and 
by establishing that the mutants exhibit abnormal sensitivi- 
ties to a  panel of toxic plant lectins. In contrast to many 
other glycosylation mutants (Stanley, 1985; Kingsley et al., 
1986c),  the diverse defects in these mutants cannot readily 
be explained by single deficiencies in the activities of either 
a glycosidase or a glycosyltransferase. Therefore, we have 
suggested that the genes defined by these mutants may affect 
the  regulation,  compartmentalization, or  activity of sev- 
eral different Golgi enzymes or substrates (Kingsley et al., 
1986a).  The  primary  biochemical  defects  in  these  cells 
might cause Golgi disruptions by: (a) blocking the synthesis 
of small and/or macromolecular substrates or their access to 
Golgi enzymes; (b) blocking Golgi enzyme transport to or 
retention at the appropriate site; (c) preventing the posttrans- 
lational  activation or  stabilization of multiple  Golgi  en- 
zymes; (d) disrupting the basic structure of the Golgi or its 
lumenal environment (pH, ion concentrations); or (e) some 
combination of these. 
In the current work, we isolated a  novel human cDNA 
(LDLC) that corrects all of the pleiotropic defects in ldlC 
cells, and we also isolated an LDLC homologue from Cae- 
norhabditis  elegans.  We have examined the expression of 
the LDLC gene and its protein product (ldlCp), and the intra- 
cellular distribution of ldlCp, in wild-type CHO and mutant 
ldlC and ldlB cells, ldlCp is a peripheral Golgi protein whose 
association with the Golgi is dependent on the LDLB gene 
and sensitive to the drug brefeldin A. The high degree of 
similarity between the sequences of the human and C.  ele- 
gans LDLC cDNAs  suggests that ldlCp mediates a  well- 
conserved cellular function. Thus, somatic cell genetic anal- 
ysis  of LDL  receptor  activity  has  defined a  previously 
unrecognized gene which plays an important role in estab- 
lishing or maintaining multiple Golgi functions. Additional 
molecular genetic and biochemical analysis of the LDLB/ 
LDLC system should provide new insights into Golgi struc- 
ture and function. 
Materials and Methods 
Materials 
Reagents (and sources) were: methionine- and cysteine-free  Ham's Fl2 me- 
dium  (GIBCO  BRL,  Grand  Island,  NY);  Na125I (Amersham  Corp., 
Arlington Heights, IL); c~[32p]dCTP, [35S]methionine,  and [3SS]dATP-a- 
S(>1000 Ci/mmol) (DuPont NEN, Boston, MA); fluorescein-conjngated 
goat anti-rabbit (FGAR) and goat anti-mouse (FGAM) IgGs (Cappel Re- 
search Reagents, Organon, Teknika,  Durham, NC); Texas red-conjugated 
horse anti-mouse IgG (TRHAM) (Vector Laboratories, Budingame, CA); 
and cell culture media and supplements (GIBCO BRL or Hazelton/JRH, 
Lenexa, KA). Newborn calf lipoprotein-deficient serum, LDL, and 125I- 
LDL were prepared as previously described (Kriager, 1983).  Lectins were 
purchased  from  Signm  Chemical  Co.,  St.  Louis,  MO. Other  reagents  were 
obtained  as  previously  described  (Kriager,  1983)  or  were purchased  from 
standard  commercial suppliers.  Compactin was a gift  of  A. Endo (Tokyo 
Nodo University,  Japan).  Antibodies  used fvr  immunofluorescence local- 
ization  experiments  include  a  polyclonal  antiserum  against  Golgi  mannosi- 
dase  II  (Moremen and  Toustcr,  1985),  and  the  anti-~-COP  monoclonal an- 
tibody  M3A5 (Allan  and Krcis,  1986). 
Cell Culture 
All incubations with intact cells were performed at 37°C in a humidified 
5 % CO2/95 % air incubator unless specified otherwise. Wild-type CHO 
cells, ldlC (clone 475)  and ldlB (clones 11  and WGAr-2)  mutant CHO 
cells, and the transfectant LETB-144 were obtained as previously described 
(Kriager et ai., 1981; Kingsley and Krieger, 1984; Kingsley et al., 1986a,b) 
and were maintained in medium A  (Ham's FI2 containing glutamine [2 
raM],  penicillin [50 U/ml  I  and streptomycin [50/~g/ml]),  supplemented 
with either 5% (vol/vol) (medium B) or 10%  (vol/vol) (medium C) FBS. 
Human HeLa and murine NIH 3T3 cells were obtained from P. Sharp and 
E  Solomon, M. L  T. (Cambridge, MA). HeLa cells were maintained in 
medium B  or C.  3T3  cells were maintained in medium D  (Dulbecco's 
Modified Eagle Medium with glutamine, penicillin, streptomycin, and 5 % 
[vol/vol]  FBS).  ldlC transfectants were maintained with or without 250 
/zg/ml  (3418  in either medium B  or medium E  which is composed of 
medium E (medium A with 3 % [vol/vol] newborn calf lipoprotein-deficient 
serum) supplemented with MeLoCo (250  #M  mevalonate, 2.5  /~g pro- 
tein/ml LDL, and 40 t~M compactin). Compactin, an inhibitor of HMG- 
CoA reductase, prevents ~holesterol synthesis by inhibiting all mevalonate 
synthesis, with the supplemented mevalonate providing only enough precur- 
sor for nonsteroidal isoprenoid synthesis; thus, the LDL is the only source 
of cholesterol for cell growth (Goldstein et al., 1979; Krieger, 1986). Con- 
sequanily, cells can grow in medium F containing MeLoCo only if they ex- 
press essentially normal levels of functional LDL receptors. 
Isolation of  LDL Receptor-positive Genomic 
Transfectants from ldlC Cells 
ldlC cells were transfected with calcium phosphate precipitates of human 
genomic DNA essentially as described by Graham and Van der Eb (1973). 
In brief, ldlC cells were plated on day 0  in medium B  (500,000  cells/ 
100-mm dish), and on day 2 the medium from each dish was replaced with 
1.5 ml of Hepes-buffered saline containing a calcium phosphate precipitate 
of genornic DNA  from human A431  carcinoma cells (20  /~g/dish)  and 
pSV2neo DNA (1/tg/dish). After 10 min, 10 ml of medium B were added. 
After a 5-h incubation, the DNA-calcium phosphate solution was removed 
and the cells in each dish were shocked with 2 ml of 15% glycerol in Hepes 
buffered saline for 3 min, washed twice in Ham's F12 medium, and in- 
cubated overnight in medium B. On day 3, the cells were refed with medium 
B and on day 4 harvested with trypsin/EDTA. Cells from each transfection 
dish were then reset into 2 100-ram dishes (4 x  106 cells/dish) in MeLoCo 
selection medium (medium F) containing 250 ~g/ml G418, to isolate pri- 
mary  receptor-positive LDL  endocytosis transfectants of ldlC cells (1  ° 
LETC cells). Five independent 1  ° LETC colonies were isolated from a total 
of 2  x  108  cells subjected to  selection. Seven independent secondary 
LETC (2  ° LETC) colonies were then isolated from 2  x  10  s cells by a sec- 
ond round of the cotransfection/selection procedure, except that genomic 
DNA isolated from one of the 1  ° LETC colonies (1  ° LETC-3C) was used 
in place of the A431 DNA. Finally,  seven tertiary LETC (3 ° LETC) colo- 
nies were isolated from 6  x  10  s cells after a  third round of cotransfec- 
tion/selection, using a  2 °  LETC  colony (2*  LETC-I5)  as the source of 
genomic DNA. 
Cloning Human LDLC cDNA 
A 3.5-bp EcoRI DNA fragment was detected in the 2 ° LETC and 3 ° LETC 
colonies by Southern blot analysis, using BLURll, a human Alu repeat ele- 
ment, as a probe (Jelinek et al., 1980).  The BLURll probe was then used 
to clone the 3.5-kbp fragment from a kZAPU (Stratagene Inc., La Jolla, 
CA) library of EcoRI-digested, size-selected DNA from 2 °  LETC cells 
(colony VS). A 600-bp SacI-HincII restriction fragment from the 3.5-kbp 
EcoRI clone, which did not contain the Alu repeat element, was then used 
as a probe to isolate candidate LDLC cDNAs from two eDNA libraries. 
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thesized both from random hexamer primers (Amersham) and from oligo 
d(T) 12-18 primers (Pharmacia LKB Biotechnology, Inc., Piseataway,  NJ) 
as previously described (Ashkenas et al., 1993).  The cDNAs were ligated 
to EcoRI/NotI adaptors (Pharmacia), size-selected (>1 kbp) by sedimenta- 
tion through 5-20%  KOAc gradients, and packaged into EcoRI-digested 
kZAPII. Plaques (5  ×  10  s) from the random-primed library were trans- 
ferred to nitrocellulose for hybridization. Eight positive clones (1-8) were 
identified, and eDNA from these clones was then used to isolate eight addi- 
tional clones (9-16) from the oligo d(T) primed library, pBluescript con- 
structs beating cDNA clones 1-16 were excised from the ~ZAPII clones ac- 
cording to the manufacturer's instructions. Partial or complete sequences 
on one or both strands from all 16 clones were determined using internal 
and  pBhiescript primers with  Sequenase 2  (United States Biochemical 
Corp., Cleveland, OH), and were assembled into a single consensus se- 
quence (EMBL accession number Z34975) with Staden DNA and protein 
analysis soRware (Cambridge, UK; see e.g., Staden, 1990).  Clone 2, which 
encompasses the complete protein coding sequence (bases 1-2214),  was 
fully sequenced on both strands. Clone 2 starts at base -15 and continues 
through base 2780.  The sequence of the 3' most 92 bases in clone 2 does 
not match the consensus sequence derived from the other clones. This 
divergent sequence is: 5"AGCTAGCTAG CTAGCTAGCT AGCTAGCTAG 
CTAGCTAGCT  AGCTAGCTAG  CTAGCTAGCT  AGCTAGCTAG  CTA- 
GCTAGCT AGCTAGCTAG CT-3'. Surveys of sequence  databases and anal- 
ysis of protein sequence motifs were performed using the programs FASTA 
and MOTIFS (with PROSITE database, version 10.2, from Amos Bairoch, 
Geneva, Switzerland) from the Sequence Analysis Software Package from 
the Genetics Computer Group at the University of Wisconsin (versions 
through 7.3) (Devereux et al., 1984),  and BLAST from NCBI (Altschul et 
al.,  1990). 
Transfection of  LDLC cDNA into ldlC Cells 
The full-length eDNA insert from clone 2  was inserted into the plasmid 
pRc/CMV (Invitrogen, San Diego, CA) to generate the expression construct 
pLDLC-1, pLDLC-1 DNA was transfected into ldlC cells using polybrene 
(Kawai and Nishizawa, 1984).  Transfected cells were isolated by selection 
in medium B containing 250/~g/ml G418. In some cases, transfectants were 
isolated by incubation in MeLoCo selection medium F with G418, to select 
directly for LDL receptor-positive transfectants. One colony transfected 
with pLDLC-I, designated IdlC[LDLCI, was used for all eDNA transfectant 
experiments presented here, and all results were verified using indepen- 
dently isolated transfectants (not shown). 
Cloning a C. elegans Homologue of  LDLC 
The C. elegans eDNA fragment CEESWg0 (GenBank accession number 
T01892)  was identified as a potential LDLC homologne (see Results). A 
probe comprising sequences from CEESWg0 was generated by PCR am- 
plification of C. elegans genomic DNA using the oligonucleotide primers 
ATGCd3TACACTTCA~GA  and  CGATTCTTTCAGCCATACCAAC. 
This  probe  was  used  to  screen a  C.  elegans eDNA  library  in  )~ZAP 
(Stratagene), prepared by R. Barstead, Washington University (St. Louis, 
MO). Six eDNA clones were isolated from 500,000 ~ZAP plaques, each 
clone being '~2.0 kbp. One clone was sequenced on both strands, and its 
sequence (EMBL accession number Z34976)  was analyzed as described 
above for the human LDLC. The sequence of its protein product was com- 
pared to that of the human protein using the BESTFIT program from the 
Genetics Computer Group, and the amino acid similarities described in Guo 
et al.,  1994  (see Fig. 4 B). 
Preparation of Polyclonal Anti-ldlCp 
Antipeptide Antibodies 
Peptides Npep (EKSRMNLPKGPDTLC) and Cpep (CAELVAAAKDQAT- 
AEQP)  were  synthesized  containing  the  predicted  NH2-terminal  and 
COOH-terminal  sequences of the ldlC protein,  with terminal cysteines 
added to permit crosslinking to carrier proteins. Npep and Cpep were cou- 
pled to  keyhole limpet hemocyanin (Sigma) preactivated with m-male- 
imidobenzoic acid N-hydroxysuccinimide ester (Sigma), and these com- 
plexes were used to prepare polyclonal antibodies in New Zealand white 
rabbits. Preimmune and immune IgGs were isolated on Protein A-Sepha- 
rose (Pharmacia) columns and are designated preimmune IgG, anti-Npep, 
and anti-Cpep. For some experiments, anti-Cpep was affinity-purified on a 
Cpep-agarnse column prepared by coupling ",,6 mg of  Cpep to a 2 rnl Solfo- 
Link column (Pierce Chem. Co., Rockford, IL); anti-Cpep was isolated af- 
ter adsorption to the column by washing the column with 100 mM Tris (pH 
8.0),  and eluting with 100 mM glyeine (pH 2.5). 
Immunoblot Analysis 
Cells were grown to confluence in medium C in 150-rmn dishes, veashed 
and collected in PBS, lysed by addition of an equal volume of 2 ×  sample 
buffer with protease inhibitors (final concentrations: 60 mM Tris [pH 6.8], 
2%  [wt/vol]  SDS,  10%  [vol/vol]  glycerol, 0.71 M  13-mercaptoethanol, 
1.5 t~g/ml aprotinin, 2 #M leupeptin, 10/zg/ml tosyl arginine methyl ester, 
0.5  mM  phenylmethylsulfonyl fuoride),  boiled,  and  passed repeatedly 
through a 25-gauge needle. Protein concentrations were determined after 
trichloroacetie acid precipitation by the Lowry method (Lowry, 1951), and 
samples  were  resolved by  electrophoresis on  0.8-ram  thick  8%  SDS- 
polyacrylamide gels (70/~g protein/ram  2) and transferred electrophoreti- 
cally to 0.22 t~m nitrocellulose (Schleicher and Schuell, Keene, NH). Ap- 
proximately 2-ram wide strips were cut, and nonspecific protein-binding 
sites were blocked by incubating the strips in buffer W (2 % [wt/vol] hemo- 
globin in PBS) for at least 1 h at room temperature. The specimens were 
then incubated overnight with primary antibody (10 tzg/ml for anti-Cpep) 
in buffer W, washed three times with buffer X (buffer W containing 0.05 % 
[vol/vol] NP-40, and 0.1%  [wt/vol] SDS), and two times in buffer W, in- 
cubated with t25I-protein A (2-10 tzCi/tzg) in buffer W  for 1-2 h, washed 
two times with buffer X, and three times with PBS. Antibody binding was 
visualized by autogradiography. Control samples for Fig. 5 and 8 A were 
probed with anti-tubulin antiserum (not shown). 
lmmunofluorescence Microscopy 
On day 0,  cells were plated (200 cells/ram  2) in medium C  onto 12-mm 
square glass cover slips. On day 2, the cover slips were washed in ePBS 
(PBS with 0.5 mM MgCI2 and 0.9 mM CaC12) at 37"C, fixed for 30 rain 
at room temperature with 3.7% (vol/vol) formaldehyde in cPBS which was 
prewarmed to 37°C, and quenched for 10 rain at room temperature in 50 
mM NI-hCI. Cells were then permeabilized for 10 min at room tempera- 
ture in PBS containing 0.1% Triton X-100 and 0.02%  SDS. The cover slips 
were then processed as follows: rinsed once quickly in PBS, preblocked for 
30 rain at 37°C facedown on a 25-/~1 droplet of blocking solution (PBS, 5% 
FBS, 0.1% Triton X-100, 0.02%  SDS) on parafilm, rinsed once with PBS, 
incubated for 90-120 min at 37°C with 25/~1 primary antibody diluted in 
blocking solution (affinity purified anti-Cpep, 3 t~g/ml; anti-B-COP mono- 
clonal antibody M3A5,  1:2 dilution; and anti-mannosidase II, 1:1000 dilu- 
tion), rinsed four times in PBS, incubated with fluorescently labeled see- 
ondary antibody in blocking solution (FGAR, 1/1,000 or 1/2,000  dilution; 
FGAM, 1/500 dilution; or TRHAM, 1.5 ~g/ml) for 45-60 rain, rinsed four 
times in PBS and one time in H20, and mounted on Vinol gel (Air Prod- 
ucts and Chemicals, Allentown, PA) with 1,4-diazabicyclo[2.2.2]octane (15 
mg/ml) (Sigma). Double-staining experiments (e.g., see Fig. 7) were per- 
formed by simultaneous addition of two primary antibodies and then addi- 
tion of the corresponding secondary antibodies. Control experiments (not 
shown) established that results from doubly stained samples were indistin- 
guishable from those of singly stained samples. Cells were examined on a 
Zeiss axioplan microscope using 40x  and 100×  oil immersion objectives 
and fluoreseein or rhodamine filter packages, and photographed with Kodak 
T-max 400 film. 
Other Methods 
Lectin sensitivity assays were performed as previously described (Kingsley 
et al., 1986a). The LD10 values presented represent estimates of the lectin 
concentrations which results in the killing of '~90%  of the cells. 
LDL receptor activity was determined using an 125I-LDL (10 #g pro- 
tein/ml, 490 cprn/ng protein) degradation assay as described previously 
(Goldstein et al., 1983; Krieger, 1983). The high affinity degradation values 
shown represent the differences  between measurements made in the absence 
(duplicate determinations) and presence (single determinations) of excess 
unlabeled LDL (400 t~g protein/ml) and are presented as rig of nSI-LDL 
degraded in 5 h per mg of cell protein. Protein concentrations were deter- 
mined by the method of Lowry et al. (1951). 
Metabolic labeling of cells, immunoprecipitation of LDL receptors with 
an anti-COOH terminus anti-peptide antibody, electrophoresis, and autora- 
diography were performed as previously described (Kozarsky et al., 1986). 
Unless  otherwise  indicated,  recombinant  DNA  and  immunological 
techniques were performed as described in Sambrook et al. (1989) and liar- 
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using Zetabind  nylon  filters  (Curio  Inc.,  Meriden,  CT) and  poly(A)  + 
RNA  Northern  blot  analyses using GeneScreen  filters  (DuPont  NEN, 
Boston, MA). 
Results 
Cloning of the Human LDLC cDNA 
To clone the LDLC gene, we adapted the strategy pioneered 
by Shih and Weinberg (1982) for the cloning of the ras on- 
cogene (see Materials and Methods for details). In brief, hu- 
man genomic DNA was transfected into ldlC cells, and LDL 
receptor-positive revertants which exhibited normal glyco- 
conjugate synthesis were isolated using a nutritional selec- 
tion method (MeLoCo, described in Krieger,  1986).  LDL 
receptor activity was determined using an LDL degradation 
assay,  which measures the receptor-dependent internaliza- 
tion and lysosomal degradation of t2SI-LDL (Goldstein et 
al., 1983; Krieger, 1983).  The global glycosylation defects 
in ldlC cells and their correction by transfection were de- 
tected using a lectin sensitivity assay (Stanley, 1985; Kings- 
ley et al., 1986a). Due to the altered structures of cell sur- 
face glycoconjugates in ldlC cells (Kingsley et al., 1986a), 
these mutants, relative to wild-type CHO, are hypersensitive 
to the lectins concanavalin A (Con A) and ricin, and resistant 
to phytohemagglutinin (PHA) and wheat germ agglutinin 
(WGA). The transfectants from this first round of transfec- 
tion/selection are designated primary (1  °) LETC cells (LDL 
Endocytosis Transfectants of  ldlC). Genomic DNA from one 
1  ° LETC line was transfected into ldlC cells to generate LDL 
receptor-positive secondary (2 °) LETC cells and an addi- 
tional round of transfection and selection was used to isolate 
tertiary (3 °) LETC cells (not shown). 
The  presence  of human DNA  in the  LETC  cells  was 
assessed  by  Southern  blotting,  using  either total  human 
genomic DNA or a  cloned fragment of human repetitive 
DNA (Alu) as the probe (not shown). In all secondary and 
tertiary transfectants examined, there was a correlation of  the 
presence of a 3.5-kbp  EcoRI human DNA-containing frag- 
ment with the  restoration both of LDL receptor activity 
p25I-LDL assay or growth in selective medium, see Mate- 
rials and Methods) and of normal glycosylation (lectin sensi- 
tivity assay). This suggested that transfer of  the human LDLC 
gene was probably responsible for the correction of the mu- 
tant phenotype in the transfected cells, and that the human 
LDLC gene was physically linked to the 3.5-kbp EcoRI frag- 
ment. Therefore, we used the Alu probe to clone this 3.5-kbp 
DNA  fragment  from  a  size-selected  library  of  EcoRI- 
digested genomic DNA prepared from a 2 ° LETC colony. 
A 600-bp Alu repeat-free SacI-HinclI restriction fragment 
from this 3.5-kbp clone was then used as a probe for North- 
ern blot analysis (not shown). Under high stringency hybrid- 
ization conditions, the probe recognized a single 3.1-3.5-kb 
mRNA from both 3 ° LETC-B6 cells and human HeLa cells, 
but not from untransfected ldIC or wild-type CHO cells. 
Thus, this mRNA was likely to be the transcription product 
of the human gene that corrected the ldlC defects. We there- 
fore used the SacI-HinclI fragment as a probe to isolate 16 
overlapping human eDNA clones from two HeLa cell cDNA 
libraries (see Materials and Methods). The cloned DNA is 
designated LDLC eDNA.  One of the clones, which com- 
prises the entire predicted coding sequence (see below), was 
inserted into the vector pRc/CMV to generate the expression 
vector pLDLC-1. 
Human LDLC cDNA Corrects the Abnormal 
Phenotypes of  idiC Cells 
Three distinguishing characteristics of ldlC cells are (a) dra- 
matically reduced LDL receptor activity, (b) abnormal post- 
translational processing (glycosylation) of LDL receptors 
and their consequent instability, and (c) global defects in cell 
surface glycoconjugates (Kingsley et al., 1986a).  To deter- 
mine if  pLDLC-1 could correct these mutant phenotypes, we 
isolated ldlC cells stably transfected with pLDLC-1. One 
transfectant, designated ldlC[LDLC], was used in the experi- 
ments described below; all results were confirmed using in- 
dependently generated transfectants (not shown).  Control 
transfectants, designated ldlC[control] cells, were generated 
by transfection with the vector pRc/CMV lacking the eDNA 
insert.  Table I  shows the LDL receptor activities, deter- 
mined using an  t25I-LDL degradation assay,  of wild-type 
CHO, ldlC, ldlC[LDLC], and ldlC[controI] cells. In the ex- 
periment shown, transfection of ldlC cells with pLDLC-1, 
but not with the empty vector, restored LDL receptor activ- 
ity to 61% of wild-type levels. Analysis of other independent 
transfectants showed that pLDLC-1 restored receptor activ- 
ity to levels as high as 160% of  wild type (not shown). There- 
fore, human LDLC eDNA restored normal LDL receptor ac- 
tivity to ldlC cells. 
Fig.  1  shows  the  posttranslational  processing  of LDL 
receptors,  using a  pulse/chase immunoprecipitation assay 
(Kozarsky et al.,  1986).  In wild-type CHO ceils the LDL 
receptor was synthesized as a ,,o125 kD precursor (p) which 
Table I. LDL Receptor Activities and Lectin Sensitivities of ldlC Transfectants 
Lectin sensitivities (LD~0)# 
LDL receptor 
Cells  activity*  WGA  ConA  PHA  Ricin  Phenotype 
ng/5 hr/mg  #g/ml  #g/ml  #g/ml  #g/ml 
CHO  1770  3  20  50  50  WT 
ldlC  183  30  5  >300  0.1  Mutant 
IdlC[LDLC]  1083  5  20  50  5  WT 
ldlClcontrol]  225  30  3  >300  0.05  Mutant 
* LDL rocep~r activity determined using an ~25I-LDL  degradation assay as described in Materials and Methods. Values represent ng ~25LLDL protein degraded 
per mg cell protein in 5 h. 
Values represent LD~0s, or the lectin concentrations sufficient to reduce cell density to 10% of that of untreated cells. Lectin sensitivity phenotypes are classified 
as WT (characteristic  of wild-type CHO cells) or as Mutant (characteristic of ldlC cetls). 
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1,  top).  Previous  experiments  have  established  that  the 
precursor is an endoglycosidase H sensitive ER protein, that 
is processed to an endoglycosidase H  resistant,  sialylated, 
mature protein during transport through the Golgi apparatus 
to the cell surface (Tolleshaug et al., 1982; Cummings et al., 
1983;  Kozarsky et al.,  1986).  The shift in electrophoretic 
mobility between the precursor and mature forms is due to 
maturation of the numerous O-linked and several N-linked 
oligosaccharides on the  receptor.  The mature form of the 
receptor is stable, with a half-life of '~16-20 h. The band of 
lower apparent mass (d) represents a previously described 
degraded form of the receptor (Fig. 1, top, and see Lehrman 
et al.,  1985;  Kozarsky et al.,  1986).  In contrast,  the LDL 
receptor in ldlC cells was converted from an apparently nor- 
mal precursor to a heterogeneous mixture of abnormally gly- 
cosylated  intermediates,  with  significantly  lower  stability 
than that of the mature receptor in wild-type cells.  (Fig.  1, 
middle,  and see Kingsley et al.,  1986a).  These abnormally 
glycosylated LDL receptors are transported to the cell sur- 
face, where they can bind LDL with normal affinity and me- 
diate endocytosis; their dramatically reduced stability is the 
primary cause of the reduction in receptor activity in ldlC 
cells (Kingsley et al.,  1986;  Reddy and Krieger,  1989).  In 
IdlC[LDLC] cells (Fig.  1, bottom), LDL receptor posttrans- 
lational processing and stability were restored to those seen 
in  wild-type cells,  while processing and  stability in ldlC- 
[control] cells remained essentially identical to those in un- 
transfected  ldlC  cells  (not  shown).  Therefore,  the  human 
LDLC cDNA corrected the abnormal posttranslational gly- 
cosylation and instability of LDL receptors in ldlC cells. 
To determine if pLDLC-1 corrected the global abnormali- 
ties in the synthesis of N-linked, O-linked, and lipid-linked 
oligosaccharides in ldlC ceils, we measured the lectin sensi- 
tivities of these transfected and untransfected cells. Table I 
shows that,  indeed,  ldlC[LDLC]  cells as well as wild-type 
CHO cells exhibited  the  wild-type (WT) pattern of lectin 
sensitivities, while ldlC and ldlC[control] cells expressed the 
mutant phenotype (hypersensitivity to ConA and ricin,  re- 
sistance to WGA and PHA).  Thus, all three major mutant 
phenotypes of ldlC cells were corrected by transfection with 
the LDLC cDNA. 
Expression of  LDLC in l~ld-type, Mutant, 
and Transfected Cells 
Plasmid pLDLC-1 could encode the human homologue of the 
defective gene in ldlC cells, or an extragenic suppressor of 
this gene (e.g., see Rine,  1991;  Reddy and Krieger,  1989). 
To address this issue, we examined by Northern blot analysis 
the expression of the endogenous LDLC gene in ldlC cells 
(Fig. 2, top).  The human LDLC probe recognized a  single 
mRNA band of ~  3.4 kb in human HeLa cells, in a 3 ° LETC 
colony, and in wild-type CHO Cells. The somewhat reduced 
intensity of the band in CHO cells relative to HeLa and 3 ° 
LETC cells was presumably due to imperfect sequence com- 
plementarity between the human and hamster homologues. 
Strikingly, this hamster LDLC mRNA was essentially unde- 
tectable in ldlC ceils, although a  longer exposure revealed 
a  very faint signal  (not  shown).  Examination of the  same 
filter with a control tubulin probe indicated that comparable 
levels of mRNA were loaded for each of the samples (Fig. 
2, bottom). The dramatically reduced levels of LDLC mRNA 
in ldlC cells relative to wild-type CHO cells reflects either 
decreased synthesis or increased degradation of the LDLC 
mRNA. Therefore, a mutation in the LDLC gene itself, or, 
perhaps less likely, in a gene which regulates LDLC mRNA 
expression, is responsible for the mutant phenotypes of ldlC 
cells. 
Human LDLC cDNA Encodes a Novel 
Cytosolic Protein 
Sequence analysis of the human LDLC cDNA clones defined 
a contiguous 2904-base pair sequence,  containing an open 
reading  frame of 738  codons.  Fig.  3  presents  the LDLC 
nucleotide and predicted ldlCp protein sequences.  The se- 
Figure 1.  Synthesis  and pro- 
cessing  of LDL receptors  in 
wild-type  CHO  cells,  ldlC 
mutants  and  IdlC[LDLC] 
transfectants. On day 0, the in- 
dicated  cells  were  plated  in 
6-well dishes  (150,000 cells/ 
well in medium E). On day 2, 
the  cells  were  pulse-labeled 
with  [35S]methionine  (180 
#Ci/ml)  in  methionine-free 
medium E for 30 min, washed 
once with Ham's FI2 medium, 
and then chased for the indicated times in medium E supplemented 
with  1 mM unlabeled methionine.  The cells were then lysed and 
the lysates subjected to immunoprecipitation with an anti-LDL re- 
ceptor  antibody  as  described  in  Materials  and  Methods.  The 
immunoprecipitates  were  reduced  with  B-mercaptoethanol,  and 
analyzed  by  6%  SDS-polyacrylamide  gel  electrophoresis  and 
autoradiography  as previously described  (Kozarsky et al.,  1986). 
The mobilities of the mature (m, 155 kD), precursor (p, 125 kD), 
and degraded (d, 118 kD) forms of  the LDL receptors in wild-type 
CHO cells are indicated. 
Figure  2.  Northern  blot  analysis 
of LDLC mRNA.  Poly(A)  + RNAs 
from the indicated cells were prepared 
and subjected to Northern blot anal- 
ysis  as  described  in  Materials  and 
Methods. (/bp) The filter was probed 
with a 32P-labeled fragment of plas- 
mid pLDLC-I that contained the full 
open reading frame. The hybridiza- 
tion  and  washing conditions  were 
chosen to permit hybridization of the 
human  probe  to  hamster  mRNA. 
Prehybridization  and  hybridization 
were carded out at 60  ° in 500 mM 
phosphate buffer (pH 7.0), 7 % SDS, 
1 mM EDTA, 10 mg/ml BSA, and 
0.1 mg/ml sheared salmon sperm DNA. Washes were as follows: 
2 x  15 min at room temperature in 300 mM phosphate buffer (pH 
7.0); 2  ×  15 min at 60  ° in 300 mM phosphate buffer, 5% SDS, 5 
mg/ml BSA, 1 mM EDq'A; and 2 ×  15 min at 60  ° in 300 mM phos- 
phate buffer, 1% SDS, and 1 mM EDTA. The arrows indicate the 
positions of the two major ribosomal  RNA bands.  (Bottom) The 
same filter was stripped and reanalyzed using a portion of/~-tubulin 
cDNA as a probe. 
Podos et al. IdlCp and Golgi Function  683 -95  ggaaactggcggtggccgcggccgccgagtcggtctgcgcatcctcctgcgttttctcgcttgga•cttggcactgagaggcggtggccggcggg  -i 
1  AT~AGAAAAGTA~ATG~CCT~CC~GGCC~ACAC~TCTGCTTCGAC~GGACGAGTTCATG~GATTTCGATGTCGATCATTTTGTGTCT~CTGTAGG~GCG~TC  120 
IMEKSRMNLPKGPDTLCFDKDEFMKEDFDVDHFVSDCRKRV40 
121  CAGCT~G~CTGAGAGATGACCTGGA~TCTACTATAAACTTCTTAAAACAGCCAT~TCG~CTCATC~C~GGATTAT~AGATTTTGTC~TCTTTC~CAAACTTGGTTG~  240 
41QLEELRDDLELYYKLLKTAMVELINKDYADFVNLSTNLVG80 
241  ATGGACAAA~CCTC~CCAGCTTTCTGTGCCTTTGGGAC~TTACGAG~GA~TTCTGAGCCTTAGATCGTCTGTCAGTG~TTCG~CAGTTGATG~CG~TGTCTAAAC~  360 
81MDKALNQLSVPLGQLREEVLSLRSSVSEGIRAVDERMSKQI20 
361  GAGGACATTAGGAAAAAAAAGATGTGTGTATTGAGGCTTATAC~GTTATTCGGTCAGTTGAGAAAATTGAAAAAATCTTAAACTCTCAAAGTTCTAAAGAAACCTCT~ACTAG~GCA  480 
121EDIRKKKMCVLRLIQVIRSVEKIEKILNSQSSKETSALEAI60 
481  A~AGCCCCCTTTTGACTGGACAAATTTTGGAGAG~TTGCCACAG~TTT~TCAGTTACAGTTTCATGCTGTTCAAAGCAAA~CATGCCTCTTTT~ACAAAGT~GACCGCGTATA  600 
161SSPLLTGQILERIATEFNQLQFHAVQSKGMPLLDKVRPRI200 
601  GcT~CATTACAGCCATGTTACAGCAGTCACTGG~GGTCTCCTATTAG~GGCCTTcAGACGTCTGAcGTCGATAT~TA~CACT~TT~GGACTTAC~ACGATTGAc~GACA  720 
201AGITAMLQQSLEGLLLEGLQTSDVDIIRHCLRTYATIDKT240 
721  CGGGACGCGGA~CCTTAGTT~CC~GTACTAGTGAAACCATACATAGAcGAGG~A~KTAGA~AGTTTGTTG~TCTCATCCC~TGGCCTTCA~TCATGTAT~TAAAcTCCTG  840 
241RDAEALVGQVLVKPYIDEVIIEQFVESHPNGLQVMYNKLL280 
841  GAGTTTGTTCCTCACCATT~CGCCTTCTTCGAG~GTCACAGGA~TGCCATCTCCAGTGAAAAAG~TACTGTTCCTGGATATGACTTTTTGGTG~TTCTGTTTG~CACAAATA  960 
281EFVPHHCRLLREVTGGAISSEKGNTVPGYDFLVNSVWPQI320 
961  GTAC~GGATTAG~GAAAAGTTACCCTCGCTTTTT~TCCTG~TCCCGATGCATTTCATGAGAAATATACCAT~GTATGGATTTTGTCAG~GATTGG~C~CAGTGT~ATCA  1080 
321VQGLEEKLPSLFNPGNPDAFHEKYTISMDFVRRLERQCGS360 
1081  CAGGCTAGTGTAAAGAGATT~GAGCCCATCCTGCCTATCACA~TTC~T~G~GTGG~CTTGCCTGTTTATTTTCAAAT~GATTTAGAGAAATAGCG~ATCCTTAG~AGCA  1200 
361QASVKRLRAHPAYHSFNKKWNLPVYFQIRFREIAGSLEAA400 
1201  CTTACAGATGTCCTGG~GAT~CCCA~TGAAAGTCCGTATTGCCTTTTGGCTTCTCATAG~CTT~GAGCAGCCTTAGGAGGTGTTGGTCAGATGAGATGTTCTTGCCATTACT~TG  1320 
401LTDVLEDAPAESPYCLLASHRTWSSLRRCWSDEMFLPLLV440 
1321  CATCGCCTGTGGAGACTCACTCTGCAGATTTTGGCACGATACTCTGTGTTTGTC~TGAGCTTTCACTCAGGCCCATTTCT~TGAAAGTCCC~GGAGATC~GAAACCTTTGGT~CT  1440 
441HRLWRLTLQILARYSVFVNELSLRPISNESPKEIKKPLVT480 
1441  GGTAGCAAAG~CCTTCCATCACCC~AAACACTG~GACC~GG~GTGGTCCTTCGGAAACAAAGCCTGT~TTTCCATTTCCCGCACTCAGCTCGTGTATGTGGTTGCAGACCTG  1560 
481GSKEPSITQGNTEDQGSGPSETKPVVSISRTQLVYVVADL520 
1561  GAC~GCTTCAGGAGCA~TTCCAG~CTCTTGGAAAT~TC~GCCAAAACTTGAAATGATTGGCTTT~G~TTTTTCTTCTATCTCAGCAGCCCT~AGGACTCCCAGA~TCTTTT  1680 
521DKLQEQLPELLEIIKPKLEMIGFKNFSS~ISAALEDSQSSF560 
1681  TCAGCCTGTGTGCCCTCCTTGAGTAGC~GATCATCCAGGATTT~GTGACTCTTGCTTCGGTTTCCTAAAAAGCGC~CTGGAGGTTCCCAGGCTTTACCG~G~CC~T~GGA~TC  1800 
561SACVPSLSSKIIQDLSDSCFGFLKSALEVPRLYRRTNKEV600 
1801  CC~CCACAGCTTCCTCCTATGTGGACAGTGCTCTG~GCCCTTATTCCAGCTTCAGAGCGGACAC~GGAT~TCAAAC~GC~T~TTCAGCAGT~CTAG~GGCACTCTCAGT  1920 
601PTTASSYVDSALKPLFQLQSGHKDKLKQAIIQQWLEGTLS640 
1921  GAAAGCACTCAT~GTACTATGAAACCGTGTCAGATGTATTAAACTCTGT~G~GATGG~GAGAGCCTGAAAAGGCTGAAAC~GCCAGAAAAACCACTCCCGCC~CCCCGTCGGT  2040 
641ESTHKYYETVSDVLNSVKKMEESLKRLKQARKTTPANPVG680 
2041  CCCAGTGGTGGCATGAGCGACGACGACAAAATCAG~TGCAGTTG~CCTAGATGTTGAGTACTTGGGAGA~AGATACAAAAGTTGGGACTAC~GTGACATAAAAAGCTT~TCA  2160 
681PSGGMSDDDKIRLQLALDVEYLGEQIQKLGLQASDIKSFS720 
2161  ~CTCTCGCAGA~CTTGTTGCT~CTGCC~GGACCAGGC~CAGCAGAGCAGCCTtaagcatcttggaagatcccgaggttagattcttaagcaagagaagagttggacttc~aggctgaa  2280 
721ALAELVAAAKDQATAEQP*  738 
2281  ggggagaaagtgactctgttctcttagcaaccgtctgtagcaaagaagtgcttccagcatcactccagcaaca•gcccatgcgtcttctctcagcgtatttgggtcttctttgcccaaaa  2400 
2401  gaacacaaaagc•tttttcca•tgtatggaagatagtttttaagacatttgaaact•tctactatagtttacagaacaaatta•tttat••ttattgtaaatcttagtgtggaagagc•g  2520 
2521  atttctaaaatatgattaaagtaaatatatacc~atgaatatcaagag~cgtctccctgagcctgtag~tggaag~gacgactg~aatggaatgatgtcttgtatagaaatgcccttctc  2640 
2641  tgaaataaagagaactcctgggctttctaaagaggctgcgggaagccatcctccactcccactgtgtgtgagagcagtgcttctgatcctgctg•caccccgacctctggcaggagccgg  2760 
2761  cgccagtaggaaagacctccttcctaaataaaagaagtgtctcccaaaa  2809 
Figu~ ~  Nucl~tide (upper line) ~d pr~ict~ amino acid (lower line) sequences of hum~ LDLC cDNA. The human LDLC cDNA ~s 
cloned ~d sequene~ and the sequence ~s  ~yz~  as descdb~ in Mated~s and Me~s.  The nucleotide sequence  is numbered so 
•  at the p~sumptive imtiator c~on stare at base 1. The arrowheads designate ~e positions of two introns. These were identifi~ ~  se- 
quencing a ~nion of ~e genomic probe which ~s  used to clone ~e LDLC cDNA. The terminal ~ur adenosines  of ~e LDLC cDNA 
a~ lilly to ~present ~e st~  of a ~ly(A) tail,  as ~ey bllow a candidate polyade~lation signal (AATAAA) ~  13 bases. 
quence surrounding the putative initiator methionine (amino 
acid no.  1)  is  consistent with the consensus sequence de- 
scribed by Kozak (1989).  This ATG is preceded by a 95-bp 
5'  untranslated  region,  which  includes  an  in-frame  stop 
codon seven triplets upstream of the start methionine. The 
2214-bp open reading frame is followed by a 595-bp 3' un- 
translated region. A  154-bp sequence within the SacI-HinclI 
genomic fragment used to clone the cDNA was identical to 
the  corresponding  sequence  in  the  cDNA  (bases  1227- 
1380). This region of the genomic DNA was flanked at both 
ends  by  unrelated  sequence,  suggesting  that  this  overlap 
defines a single exon within the LDLC gene (see arrowheads 
in Fig.  3). 
The predicted protein product (ldlCp) of the human LDLC 
gene has a calculated mass of 83,207  D.  Surveys of various 
DNA  and  protein  sequence  databases  have  revealed  no 
similarities to any known genes or proteins.  Furthermore, 
we have detected no signal sequences for translocation into 
the  ER,  and  no  candidate  transmembrane domains.  This 
suggests that the ldlCp is a novel, soluble protein which does 
not enter the secretory pathway and is probably a cytoplas- 
mic protein. Thus, it appears that LDLC encodes a protein 
that influences lumenal Golgi reactions from the cytoplasm. 
In addition,  we have  not detected  any other common se- 
quence motifs or predicted secondary or tertiary structural 
elements, such as isoprenylation sequences, amino terminal 
N-myristylation sites,  nucleotide binding  sites,  heptad  re- 
peats,  etc. 
We have found no notable sequence similarities between 
LDLC and known genes reported in databases such as Gen- 
Bank  and  EMBL.  However,  the  LDLC  cDNA  sequence 
was significantly  similar to three expressed  sequence tags 
(ESTs), cDNA fragments which were cloned and sequenced 
at  random.  Two  of the  ESTs  were  derived  from  human 
cDNA  libraries  (EST01264  from hippocampus,  GenBank 
no. M79116,  Adams et al.,  1992;  and EST clone HEB069 
from heart atrium, GenBank no. Z25929, Genexpress, unpub- 
lished observations). These two ESTs are nearly identical to 
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tively. The few mismatches are probably due either to poly- 
morphisms or to sequence errors arising from the preliminary 
nature of EST sequences (Adams et al.,  1991). The third 
EST (CEESW90; GenBank no. 191892, McCombie, W. R., 
J. M. Kelley, L. Aubin, M. Goscoechea, M. G. Fitzgerald, 
A. Wu, M. D. Adams, M. Dubnick, A. R. Kerlavage, J. C. 
Venter, and C. A. Fields, unpublished information) was ob- 
tained from the nematode Caenorhabditis elegans. 
Cloning of  an LDLC homologue from C. elegans 
The C.  elegans EST clone is 382 bases long, and includes 
a 203-bp region which is 60% identical to bases 40-242 of 
the human LDLC cDNA. Furthermore, the predicted amino 
acid sequence within this region is 49% identical and 70% 
similar to the human ldlCp sequence. Therefore, the gene 
represented by this EST was a good candidate for an inver- 
tebrate homologue of the LDLC gene. To characterize the 
putative homologue, we used this EST to isolate six C. ele- 
gans cDNA clones. Each was '~2.0 kbp long, and they all 
had similar restriction maps. One clone was sequenced fully 
on both strands (see Fig. 4 A). Its 2222 base sequence in- 
cludes an open reading frame of 681  codons from the first 
methionine (Fig. 4 A). The sequence surrounding the puta- 
tive  initiator codon is  consistent with  the  consensus  se- 
quence described by Kozak (1989).  The reading frame is 
preceded by a putative 31-bp 5' untranslated region which 
lacks in-frame stop codons; this 5' untranslated region in- 
cludes a T~s which may be an artifact of cDNA synthesis. 
The open reading frame is followed by a  148-bp 3' untrans- 
lated  region  which  includes  a  20-bp  polyadenylate tail. 
Throughout their lengths, the predicted protein sequences of 
the C.  elegans (calculated mass of 78,565  D) and human 
ldlCp homologues are 26 % identical and 53 % similar when 
aligned as in Fig. 4 B. The first methionine in the human se- 
quence best corresponds to the methionine at position 10 of 
the C. elegans sequence, raising the possibility that the first 
nine amino acids of the C. elegans sequence in Fig. 4 A may 
not be translated. These nine residues include a  potential 
myristylation site. As with its human counterpart, the nema- 
tode ldlCp sequence lacks other notable structural features 
such as transmembrane domains or signal sequences. Over- 
all, the conservation in the human and nematode ldlCp se- 
quences suggests that the LDLC genes encode proteins which 
mediate important, highly conserved functions. 
Preparation and Characterization of 
Anti-ldlCp Antibodies 
Based  on  the  abnormalities  in  medial  and  trans  Golgi- 
associated  glycoconjugate synthesis in  ldlC  cells,  we  in- 
ferred that cytosolic ldlCp might physically associate with 
the Golgi apparatus. To determine the subcellular distribu- 
tion of ldlCp  by  inununofluorescence microscopy,  rabbit 
polyclonal antibodies were prepared using synthetic peptides 
which represent the amino (Npep)-  and carboxy (Cpep)- 
termini of human ldlCp, and are designated anti-Npep and 
anti-Cpep, respectively. Both immunoprecipitation and im- 
munoblot analyses (not shown) established that anti-Npep 
and anti-Cpep antibodies bound to an '~76-kD protein which 
was present in HeLa cells (not shown). This binding was 
specifically blocked by an excess of soluble peptide, and this 
76-kD protein, whose apparent mass is similar to the 83-kD 
predicted from the LDLC sequence, was not detected when 
either preimmune serum was used. 
Anti-Cpep was affinity purified on a  Cpep-agarose col- 
umn, and its specificity was assessed by immunoblot analy- 
sis. Fig. 5 compares the immunoblotting patterns of preim- 
mune IgG (p) and anti-Cpep (C), measured in the absence 
(-)  or  presence  (+)  of an  excess  of the  Cpep  peptide. 
Purified anti-Cpep,  but not preimmune IgG, bound to an 
•76-kD  protein in both human HeLa cell and murine 3T3 
cell lysates (anti-Cpep, Fig. 5,  lanes 2  and 5;  preimmune 
IgG, lanes 1 and 4). This binding was competed by excess 
Cpep,  suggesting that it may correspond to ldlCp (Fig. 5, 
lanes 3 and 6). Anti-Cpep, but not preimmune IgG, also rec- 
ognized two smaller species in the HeLa cell lysates (Fig. 5, 
lanes I and 2); however, this binding was not inhibited by ex- 
cess Cpep (lane 3). The identities of these smaller molecules 
and the significance of their recognition here are unknown. 
Anti-Cpep also specifically recognized the ~76-kD endoge- 
nous hamster IdlCp in CHO cell lysates (Fig. 5, lanes 7-9). 
The ~76-kD protein was not detected in lysates from ldlC 
ceils (Fig. 5, lanes 10 and 1/), but was seen in IdlC[LDLC] 
lysates (lanes 12 and 13). (Replicate lanes of CHO, ldlC, and 
ldlC[LDLC]  lysates,  stained  with anti-tubulin antiserum, 
showed that these samples contained equivalent amounts of 
protein [not shown]). These results are consistent with the 
dramatically reduced levels of LDLC mRNA observed in 
ldlC cells (Fig. 2).  As was the case for HeLa cell lysates, 
anti-Cpep bound to smaller, unidentified species from CHO 
and ldlC cells. Taken together, these data establish that the 
•76-kD  protein, which is the major specific antigen of anti- 
Cpep, is ldlCp and they suggest that at least a portion of the 
COOH terminus of ldlCp is conserved among several mam- 
malian species. 
lmmunolocalization of ldlC Protein 
Immunofluorescence microscopy with affinity purified anti- 
Cpep was used to determine the distribution of ldlCp within 
wild-type CHO cells. Fig. 6 a (top left) shows that the ma- 
jor anti-Cpep signal in CHO cells emanated from clearly 
defined, punctate, and sometimes annular,  structures sur- 
rounding the nucleus. This perinuclear staining was absent 
from ldlC cells but present in transfected IdlC[LDLC] cells 
(see below), and was largely competed by a  10-fold molar 
excess of soluble Cpep (not shown). Thus, the perinuclear 
staining represents the localization of ldlCp. A fine, granu- 
lar, yet otherwise uniform, background was often present. 
This background was resistant to Cpep competition, and was 
indistinguishable from the staining pattern observed with 
preimmune IgG or in controls in which the primary antibody 
was omitted (not shown). 
The perinuclear distribution of ldlCp was characteristic of 
the distribution of  the Golgi apparatus in CHO cells (Kao and 
Draper,  1992;  Guo et al.,  1994).  For example, Fig. 6 (top 
row) also shows the staining of CHO cells with antibodies 
against two Golgi-associated proteins: fl-COP (b) and man- 
nosidase II (c). fl-COP is a subunit of the Golgi coatomer 
complex, which associates reversibly with Golgi membranes 
and which is a major component of the protein coat on Golgi- 
derived transport vesicles (Duden et al.,  1991; Serafini et 
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-31  gtttttttttttttttgaaaatatttttaaa  -i 
1  ATGGGTACACTTCATGGCGAGAAAAcTATGTTCGCTTCGCCAAACAcCTTCTATATCGATG~TCG~GTTATGC~T~T~GACcCATTTC~TCGAG~GATTTT~TGTGG~CGA  120 
IMGTLHGEKTMFASPNTFYIDESKLCFNKTHFNREDFNVER40 
121  TTTATG~CTTGGC~GGCAAAAATCTGATCTCAAAAC~TTCAGCAGGATCTACGCCTCTACTTGAAAAGTGTTCAAAATTC~TGATCGAG~TATC~CGATGATTATGCGGATTTT  240 
41FMNLARQKSDLKTIQQDLRLYLKSVQNSMIELINDDYADF80 
241  GTCCATTTATCGTCAAACTTGGTCAGCCTCC~GACTCACTAAATAAAATCG~C~GATATC~TAG~TATGGGATG~TTC~GGAGTCGAC~GAG~TCTGTTGGTATGGCTG~  360 
81VHLSSNLVSLQDSLNKIEQDINRIWDEFKESTRESVGMAEI20 
361  AG~TCGAGCAAAAATGTGATGAG~TTGCTCAAATCGAGAAAAACAAATTGAAATTCGGGATCGCATTTATTTTCTAGTTGCCATAGAAAAGCTATCAGAAATG~ATTGCATCCTCCT  480 
121RIEQKCDELCSNREKQIEIRDRIYFLVAIEKLSEMLLHPPI60 
481  CGAAAATGCTCTG~TTGTGGTTACAAAAGGCAGCGTCCTTCGCATCAGAGCTG~GGGTTCCACGTTTCCCCATTCGG~GAGGAAAATGCCGCTGAAAAGAT~TTCTATCTCAGCTG  600 
161RKCSALWLQKAASFASELKGSTFPHSEEENAAEKIILSQL200 
601  G~GCGGTTCTCTGTGCAG~GGAGTTCG~GTGCCGCCGGTGATTGTCAAAATCTTCCTCTCATTTATTC~TT~ATCGTT~CGGAGAGTACGCA~CACT~CTGCCCTcTTGGTT  720 
201EAVLCAEGVRSAAGDCQNLPLIYSILSLTESTHSLTALLV240 
721  TCTGATCT~TGTATGCCG~TTTGTAAATGAGAAACACGACGAAAGT~TCAGTTGAAA~CTTGAAAC~GTCTTCGAAAGCGTCAAAAAAATGCGTGAAACTTGGGCTGAAAAAATG  840 
241SDLLYAEFVNEKHDESNQLKLLKQVFESVKKMRETWAEKM280 
841  GGGACTG~CAT~TCGT~GAAACATCCGCCGTTTTCTGGACGAAACCCTTCTCACGTTCATTCTGACATTTATTGAT~GTGTATGGGAGCCGTCGCAGTCCC~GTGACACACGACTT  960 
281GTEHFR~NIRRFLDETLLTFILTFIDKCMGAVAVPSDTRL320 
961  TTCCATG~TGTTTCTTGCTCACTC~G~TTTATCGAT~TTGGCCATCTTCTCATACCTGCC~TGC~TGCTT~GTCGATCAGGGATAAATTC~TTTATTAGTTTATT~AAATTA  1080 
321FHECFLLTQEFIDNWPSSHTCRAMLHSIRDKFNLLVYFKL360 
1081  GAAACACATCGATTCGGAAAACAGTGCGATCAGCTGATGTCTCCCGAAATG~TGCCGAGCCAGAAACTTCTGAAAATCGAGAAAACACTC~CAGCTCCACTGCGGAGTTTC~GAGCA  1200 
361ETHRFGKQCDQLMSPEMFAEPETSENRENTPQLHCGVSRA400 
1201  A~AT~CAGC~TTGAGCATGTGTGGAGTGATGATGTGTATCTTCCTCCTATTGTTGATAAA~ATGGGATTTCACATTG~GCTTTTGCTAAAGCATTTCTCGTGGAGTCAAACTATG  1320 
4011ITA~EHVWSDDVYLPPIVDKLWDFTLKLLLKHFSWSQTM440 
1321  AAAAATTATTTCATGG~GAAAAAAGAGATTGGACTTC~TGGTTACTCTCCGCTCGGATACTGGAAATCTTCATC~TTGGTTTTCGATTTCGCGTT~GAGTC~T~GGGGAAAATTT  1440 
441KNYFMEEKRDWTSMVTLRSDTGNLHQLVFDFALESIWGKF480 
1441  CATGATATCACAGTGGATACCGCTCCATTCGGTC~TGCCT~CAAAGCATGGTCGATC~TTGATAGTCTTTGTGTTCAAATTGATGATAGTATTATTGAAATGTTCTCCG~GTTCTT  1560 
481HDITVDTAPFGQCLTKHGRSIDSLCVQIDDSIIEMFSEVL520 
1561  CATC~GAAATTGCTC~GTTTCCGATGTTCCTAAAC~TACAGATGGACG~GAAATCACCACCGAC~CGCA~CCAAATATGTTGTTACAGCTATTGAAATGGTTGAG~TTTGAAA  1680 
521HQEIAQVSDVPKQYRWTKKSPPTTHSKYVVTAIEMVENLK560 
1681  GAAAAACTATGCTGCG~G~CATCCTCACACCGATGAAATTGTTCGAAAAGTT~TCTTTCAGCATTC~TTATTTCGTGGGGAAAGGG~CGAGGTG~GGATAGTGTCG~GCTACA  1800 
561EKLCCEEHPHTDEIVRKVNLSAFNYFVGKGNEVLDSVEAT600 
1801  GGATCTTCTTTATCCCGATTCAAACGGAAAACCAC~CTGATTCTGGCTCCACGGTTACTGATGACGATAAAATCAAAC~CAAATCTATCATGATGCTAAATATTTCCTGAGCTATGCG  1920 
601GSSLSRFKRKTTTDSGSTVTDDDKIKQQIYHDAKYFLSYA640 
1921  GAAAATCTTGTATTCTCAC~GCTGATCTCACCGGATTAC~G~GTCGTC~TCGATTTGACAAAGATGCACGTTCGGCGATTGTAC~GAGAAAAATCAG~CG~G~GcGGGG~T  2040 
641ENLVFSQADLTGLQEVVNRFDKDARSAIVQEKNQNEEAGN  680 
2041  GCTtgaattaattttatgtgattatttatttacatgtacattttattttaacaaatgggttgaagtctttaaaatCgt•tattgccttaatatgggttCa•ggtattggaataaaaagtg  2160 
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Figure 4. Nucleotide and predicted amino acid sequences of the Caenorhabditis elegans LDLC cDNA (A), and alignment of the protein 
sequences of the human and C. elegans homologs (B). (A) The C. elegans LDLCcDNA was cloned and sequenced as described in Materials 
and Methods.  The presumptive initiator codon starts at base 1 (however,  see text for further discussion). The 3'-terminal 20 adenosines 
are likely to represent the start ofa poly(A) tail, as they follow a candidate polyadenylation signal (AATAAA) by 16 bases. (B) Alignment 
of the human and nematode ldlCp amino acid sequences. Vertical bars indicate identities, double and single dots indicate strong and weak 
similarities. 
The Journal of Cell Biology, Volume 127, 1994  686 Figure 5. Immunoblot Analysis of ldlCp. The indicated cells were 
grown to confluence and lysed, and the lysates subjected to immu- 
noblot analysis using either preimmune IgG 00/zg/ml, p) or anti- 
Cpep (10 t~g/ml, C), the latter in the presence (+) or absence (-) 
of  a 10-fold  molar excess (2 #g/ml) of  the Cpep peptide. Bound anti- 
body was detected autoradiographically using ~25I-Protein  A. The 
"ldlCp  ~ (/arge arrow) indicates the position of the various mam- 
malian ldlCp's, as described in Results. 
al., 1991; Waters et al., 1991; Ostermann et al., 1993). Man- 
nosidase II is an integral membrane protein required for nor- 
mal processing of N-linked oligosaccharide chains in the lu- 
men of the Golgi apparatus (Moremen and Touster, 1985). 
The perinuclear immunofluorescence of ldlCp and t-COP 
colocalized  (Fig.  6,  a  and  b  show  essentially  the  same 
field from a doubly-stained sample), and their distributions 
clearly resembled that of mannosidase II.  Thus,  ldlCp ap- 
pears to be a  Golgi-associated protein in  wild-type CHO 
cells.  Similar  results  were obtained  using  3T3  cells  (not 
shown). 
Effects of Brefeldin A  on the Localization of ldlCp 
Because the sequence of ldlCp suggested that it is a cytosolic 
protein,  it  appeared  likely  that  ldlCp  would  associate 
peripherally, rather than integrally, with Golgi membranes. 
We therefore compared the behavior of ldlCp with those of 
the peripheral Golgi protein/3-COP and the integral mem- 
brane  protein rnannosidase  II,  when  the  structure of the 
Golgi  apparatus  was  disrupted  with  the  drug  brefeldin A 
(BFA) (Takatsuki  and Tamura,  1985;  Fujiwara et al.,  1988; 
Donaldson et al.,  1990;  Lippincott-Schwartz et al.,  1989, 
1990; Orci et al.,  1991).  BFA interferes with the assembly 
of the coatomer complexes onto Golgi membranes resulting 
in  the  division  of Golgi-associated proteins  into  at  least 
two kinetically and morphologically distinguishable groups. 
~COP and other peripherally associated coat proteins rap- 
Figure 6.  Immunofluorescence localization of ldlCp, B-COP and 
marmosidase II in CHO cells:  effects  of BFA. CHO cells  were 
grown on glass cover slips as described in Materials and Methods. 
Before fixation and immunostaining, the cells were treated as fol- 
lows: no additions (a-c) or incubation with 5 #g/mi BFA for two 
(d-J)  or five (g-i) min.  Cells were immunostained with peptide 
afffinity-purified  anti-Cpep (a, d, and g), anti-B-COP monoclonal 
antibody M3A5 (b, e, and h), and anti-mannosidase II (c,f, and i) 
as described in Materials and Methods. Specimens were simultane- 
ously double stained with the anti-Cpep and anti-B-COP antibod- 
ies, and the corresponding identical fields are shown. 
idly redistribute from the Golgi surface into the cytoplasm 
(Donaldson et al.,  1990).  Subsequently,  the Golgi mem- 
branes and their integrally associated proteins, such as man- 
nosidase II, more slowly fragment into tubules and vesicles, 
which then mix with the endoplasmic reticulum. The effects 
of BFA on the distributions of  B-COP and mannosidase II are 
reversed after the drug is removed from the cells (Donaldson 
et al.,  1990). 
Fig.  6  shows ldlCp's redistribution following BFA treat- 
ment (left column),  compared with those of B-COP (center 
column) and mannosidase II (right column).  After 2 min of 
BFA treatment (Fig. 6, second row), perinuclear ldlCp was 
reduced but still evident, and the cytoplasmic staining in- 
creased (d). After 5 min (third row), only small remnants of 
perinuclear staining were observed (g). In this regard, the 
effects of BFA on the distribution of ldlCp resembled those 
on ~-COP, which was reduced in intensity after 2 rain and 
dispersed after 5 min (e and h). In contrast, mannosidase II 
staining was largely unchanged after 2 min (f). After 5 min 
it had transformed into a more contiguous pattern which in- 
cluded  some  fiber-like projections  (i),  as  previously de- 
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of BFA treatment, the staining of ldlCp and of/3-COP were 
distinct from that of marmosidase II. The staining with all 
three antibodies was almost fully dispersed after 20 rain of 
BFA treatment, and was restored to an essentially normal 
distribution after the BFA was removed and the cells were 
permitted to recover for 30 min (not shown). Taken together 
with the predicted sequence of ldlCp,  these data strongly 
suggest  that  ldlCp  is  peripherally  associated  with  the 
Golgi apparatus and its association appears similar to that of 
&coP. 
To determine if ldlCp was required to maintain the normal 
structure of the Golgi apparatus, we compared the distribu- 
tions  of/~-COP  and  mannosidase  II  in  CHO,  ldlC,  and 
ldlC[LDLC]  cells.  Fig.  7  shows  that  the  distributions  of 
/~-COP (center column) and mannosidase 1I (right column) 
were essentially identical in all three types of cells, regard- 
less of the presence or absence of ldlCp (left column).  Thus, 
expression of ldlCp was not required for the formation of the 
Golgi.  It should be noted that the intensities of the peri- 
nuclear staining of the Golgi markers varied among these 
cell types. In general, there was a tendency for somewhat re- 
duced perinuclear/~-COP and mannosidase II staining inten- 
sity in ldlC cells. Expression of  the transfected human ldlCp 
in IdlC[LDLC] cells elevated the intensity of these two mark- 
ers to wild-type, and often even greater than wild-type levels. 
The significance of these differences in staining intensities 
remains unclear, but may reflect a  subtle role of ldlCp in 
regulating the structure or quantity of Golgi membranes. 
Aberrant Distribution of ldlCp in ldlB Cells Indicates 
Golgi Localization Is Required for IdlCp Function 
The BFA-dependent reversible localization of ldlCp to the 
Golgi suggested that, as with 13-COP, Golgi localization may 
be required for the effects of ldlCp on Golgi function. This 
suggestion was supported by studies of ldlCp's distribution 
in another class of CHO cell mutant, ldlB. ldlC and ldlB cells 
are genetically distinct; they define discrete recessive com- 
plementation  groups  (Kingsley  and  Krieger,  1984),  and 
transfection of the cloned LDLC cDNA into ldlB cells did 
not correct the pleiotropic defects of ldlB cells (not shown). 
Nevertheless, the mutant phenotypes of ldlB and ldlC cells 
are virtually indistinguishable: reduced LDL receptor activ- 
ity,  abnormal posttranslational processing and  stability of 
LDL receptors, and global defects in cell surface glycocon- 
jugates (Kingsley et al.,  1986a). This raised the possibility 
that the LDLB gene could exert its effects on Golgi function 
by regulating the expression or function of the LDLC gene 
or of ldlCp. We therefore examined the expression of the en- 
dogenous LDLC gene and the localization of ldlCp in a clone 
of ldlB cells, designated ldlB-ll, and in a secondary human 
genomic DNA transfectant of ldlB-11  cells, designated 2 ° 
LETB-144, in which the mutant phenotypes had reverted to 
wild type (Kingsley et al.,  1986b). 
Northern blot analysis (not shown) and immunoblot analy- 
sis (Fig.  8 A) established that there were essentially wild- 
type levels of both LDLC mRNA and ldlCp, in both ldlB-11 
and 2 ° LETB-144 cells. Thus, LDLB gene function was not 
required for the synthesis or maintenance of normal steady- 
state levels of ldlCp. Fig. 8 B shows the immunofluorescence 
localization of ldlCp (left column),/3-COP  (middle column) 
Figure 7. Immunofluroescence localization of ldlCp, B-COP and 
mannosidase lI in CHO, ldlC and ldlC[LDLC] cells. The indicated 
cells were grown on coverslips and immunostained with peptide 
affinity-purified  anti-Cpep (a, d, and g), anti-/~-COP monoclonal 
antibody M3A5 (b, e, and h), and anti-mannosidase II (c,f, and i) 
as described in Materials and Methods. 
and mannosidase II (right column)  in wild-type CHO (first 
row), ldlB-11  (second  row), and 2 °  LETB-144 cells (third 
row). In contrast to its typical Golgi localization in wild-type 
CHO cells (a), ldlCp apparently did not localize to the Golgi 
apparatus in ldlB-11  ceils (d). Instead, a uniform punctate 
background in ldlCp staining was seen, suggesting that ldlCp 
was distributed throughout the cytoplasm of ldlB-11  cells. 
These  results  were  confirmed by  examining  an  indepen- 
dently derived clone of ldlB cells (WGAr-2, Kingsley et al., 
1986a) (not shown). In addition, the normal Golgi distribu- 
tion of ldlCp was restored in 2 ° LETB-144 ceils (g). In both 
ldlB-11 and 2 ° LETB-144 cells, there were essentially wild- 
type distributions of/~-COP (center  column,  b,  e, and h) 
and mannosidase II (right column,  c, f,  and i),  indicating 
that the Golgi in these cells was essentially normal. As was 
the case for ldlC cells, there was a tendency for the intensity 
of immunofluorescence to be lower in the mutant than in 
wild-type or phenotypically reverted transfected cells; the 
significance of this observation is unclear. Taken together, 
these results establish that the LDLB gene is necessary for 
ldlCp localization to the Golgi and raise the possibility that 
the distinctive mutant phenotypes of ldlB cells are primarily 
due to abnormal localization of ldlCp. 
Discussion 
Three distinguishing characteristics of ldlC cells are their (a) 
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tion (B) of IdlCp,/3-COP and mannosidase II in CHO, ldlB, and 
LETB cells. (A) The indicated cells were grown to confluence and 
lysed, and the lysates subjected to immunoblot analysis using anti- 
Cpep (10 ttg/ml). Bound antibody was detected autoradiographi- 
cally using ~25I-Protein  A. (B) The indicated cells were grown on 
coverslips and immunostained with affinity purified anti-Cpep (a, 
d, and g), anti-5-COP monoclonal antibody M3A5 (b, e, and h), 
and anti-mannosidase II (c, f, and i) as described in Materials and 
Methods. 
dramatically reduced LDL receptor activity, (b)  abnormal 
posttranslational processing (glycosylation) of LDL recep- 
tors, resulting in receptor instability, and (c) global defects 
in  cell  surface  glycoconjugates (N-linked,  O-linked,  and 
lipid-linked oligosaccharides) (Kingsley et al.,  1986a).  Es- 
sentially identical defects are found in a genetically distinct 
class of CHO mutants, ldlB cells. All of these abnormalities 
arise from pleiotropic defects in multiple medial and trans 
Golgi-associated processes  (Kingsley et al.,  1986a).  The 
complex nature of these defects suggests that the LDLB and 
LDLC genes may be critically important for generating or 
maintaining  the  compartmental  organization  or  the  in- 
tralumenal environment of the Golgi apparatus (Kingsley et 
al.,  1986a). 
In the current study, we cloned a  human LDLC cDNA 
which corrects the mutant phenotypes of ldlC, but not ldlB, 
cells. Unlike wild-type CHO or ldlB cells, ldlC cells had vir- 
tually no detectable endogenous LDLC mRNA, suggesting 
that LDLC is the normal human homologue of the defective 
gene in ldlC cells. Alternatively, the cloned LDLC gene may 
have acted as an extragenic suppressor of the defective gene 
in the ldlC cells. In either case, it appears that the gene which 
is defective in ldlC cells either directly or indirectly controls 
the expression of the LDLC mRNA and its protein product 
(ldlCp), and ldlCp apparently plays an important role in the 
normal functioning of the Golgi. 
The predicted  sequence  of ldlCp is  novel,  lacking sig- 
nificant similarity to other known proteins. A portion of the 
ldlCp sequence was, however,  highly similar to that of an 
EST cDNA  fragment from the nematode C.  elegans.  We 
cloned and sequenced the C.  elegans cDNA, and found a 
high degree  of sequence  similarity throughout the entire 
lengths of the mammalian and nematode sequences  (26% 
identity, 53 % similarity). This similarity suggests that ldlCp 
plays an ancient role in eukaryotic cell biology. The highly 
conserved portions of these sequences should facilitate the 
construction of probes which will permit the identification 
of ldlCp homologues from other species, possibly including 
the  yeast  Saccharomyces  cerevisiae.  Genetic  studies  in 
C.  elegans and S.  cerevisiae should help further define the 
functions of ldlCp. 
The predicted sequence of ldlCp has no major common 
structural motifs such as GTP binding sites, transmembrane 
domains, or an ER translocation signal sequence. This sug- 
gests  that  ldlCp  is  a  cytoplasmic protein.  Nevertheless, 
immunofluorescence studies  indicated that ldlCp  may be 
associated  with  the  cytoplasmic face of the  Golgi,  as  it 
colocalized  with  Golgi  markers  and  was  rapidly  redis- 
tributed from the Golgi by the drug BFA. Thus, the associa- 
tion of ldlCp with the Golgi appears to be analogous to that 
of several  other peripheral Golgi proteins, including p200 
(Narula et al., 1992), the coatomer (Donaldson et al., 1990; 
Orci et al., 1991), the small GTPase ADP-ribosylation factor 
(ARF) (Klausner et al., 1992),  clathrin, and type I clathrin- 
associated proteins (Robinson and Kreis, 1992; Stamnes and 
Rothman,  1993;  Traub et al.,  1993),  most of which have 
been  implicated in intracellular membrane transport.  Be- 
cause ARF and coatomer proteins cycle on and off of Golgi 
membranes in a guanine nucleotide-dependent fashion (for 
example see Donaldson et al.,  1992;  Helms and Rothman, 
1992; Klausner et al., 1992),  it seems likely that ldlCp may 
undergo similar cycling between the cytoplasm and the Golgi 
membranes.  The relative amounts of Golgi-associated and 
cytoplasmic ldlCp and the affinity of ldlCp for Golgi mem- 
branes have not yet been determined. The reversible nature 
of ldlCp association with the Golgi suggests that the associa- 
tion may be regulated. Regulated association of Golgi pro- 
teins has been implicated in the mitotic disassembly of the 
Golgi,  as  well  as  in  normal  trafficking during  interphase 
(Rothman and Warren,  1994). 
Podos et al. ldlCp and Golgi Function  689 I A  = IdlCp J 
Phenotype 
Normal  I  Golgi 
Processing 
+BFA T -BFA 
Golgi 
,',I/',  [',  !  Pleiotropic  I  I  -. 
Golgi  L  ~ 
Defects  IdlC  IdlB 
Figure 9. Model of the effects of BFA treatment and ldlC and ldlB 
mutations on ldlCp and Golgi function, ldlCp (triangles) is a BFA- 
sensitive peripheral Golgi protein (top) required for normal medial- 
and trans-Golgi processing reactions. Abnormal processing of gly- 
coproteins and glycolipids in the lumen of the Golgi occurs when 
ldlCp is not associated with the Golgi, either because ldlCp is not 
synthesized (ldlC mutants, lower left) or because it cannot associate 
with the Golgi in the absence of normal LDLB gene function (ldlB 
mutants, lower right). 
Analysis of ldlB mutants suggested that the association of 
ldlCp with the Golgi apparatus is required for its normal 
function. Essentially wild-type levels of ldlCp were present 
in ldlB cells; however, immunofluorescence microscopy in- 
dicated that the ldlCp was not localized to the Golgi complex 
in ldlB ceils. A simple model, which accounts for the virtu- 
ally identical phenotypes of ldlB and ldlC cells (Kingsley et 
al., 1986a), is that the product of the LDLB gene is required 
for the Golgi association of ldlCp and that this association 
is  required  for  ldlCp  function.  When  this  association  is 
prevented, due either to the absence of the ldlCp or to the 
loss of functional ldlBp, normal Golgi processing reactions 
are disrupted  (See Fig.  9).  ldlBp might serve as a  Golgi 
receptor for ldlCp,  a component of a heterooligomer with 
ldlCp, or a processing enzyme that renders ldlCp competent 
to bind to Golgi membranes. Further experiments will be re- 
quired to determine how ldlBp influences the localization 
and activity of ldlCp, and what other roles the LDLB gene 
may play in normal Golgi functions. 
The mechanism by which ldiCp influences lumenal Golgi 
processing reactions has  not yet been established.  At the 
resolution of the immunofluorescence microscopy described 
here, we observed no major defects in the ultrastructure of 
the Golgi in ldlC cells. Nevertheless, ldlCp might play a role 
in determining the compositions of the Golgi's membranes 
or lumenal spaces, including the amounts or types of pro- 
teins, lipids, carbohydrates, or ions present. Alterations in 
the localization or amounts of these components could inter- 
fere with multiple Golgi processing reactions. For example, 
the distributions of enzymes within the Golgi may depend on 
the distributions of lipids (Bretscher and Munro,  1993). It 
is  also  possible  that  the  membrane  association of ldlCp, 
which is BFA sensitive, is required for normal membrane 
trafficking through the Golgi. A defect in transport through 
one or more of the Golgi stacks  might result in pleiotro- 
pic processing defects without grossly disrupting either the 
Golgi's ultrastructure or protein transport to the cell surface. 
Additional biochemical and genetic studies will be required 
to determine the functions of ldlCp, and how these functions 
contribute to the normal activity of the Golgi apparatus. 
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